MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Revenue
$31,687K
Net Income
-$63,774K
Net Profit Margin
-201.26%
EPS
-$0.18
Unit: Thousand (K) dollars
Revenue Breakdown
Product
License
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Total revenue
31,687
83,228
41,865
13,120
Cost of revenue
-
-
-
3,349
Cost of sales
911
375
214*
-
Gross profit (deficit)
-
-
-
9,771
Cost of collaboration and license agreements revenue
8,560
5,616
9,084*
-
Research and development
30,661
35,047
34,297
28,846
Acquired in-process research and development
-
-
0*
0
Selling, general and administrative
42,591
38,309
40,326
37,359
Total costs and expenses
82,723
79,347
83,921
66,205
Loss from operations
-51,036
3,881
-34,037
-56,434
Interest income
4,596
5,108
5,296
6,033
Interest expense
6,759
6,708
6,673
6,534
Investment advisory fees
184
195
166
171
Loss on debt extinguishment
-9,472
-
-
-
Change in fair value of warrant liability
0
-2,865
1,127
-612
Realized gain (loss) on marketable securities
9
8
3
0
Net loss (gain) on disposal of fixed assets
1
-
12*
4
Other income (expense)
-
-
100*
-
Other income
5
438
-
698
Total other (expense) income, net
-11,804
1,516
-2,555
642
Income (loss) before income taxes
-62,840
5,397
-36,592
-55,792
Provision for income taxes
0
0
0
0
Net loss
-62,840
5,397
-36,592
-55,792
Currency translation adjustment
471
268
1,007
313
Change in unrealized loss on available-for-sale securities
-463
-1,222
958
501
Comprehensive loss
-63,774
3,907
-36,641
-55,604
Basic EPS
-0.18
0.02
-106.387
-0.16
Diluted EPS
-0.18
0.01
-106.387
-0.16
Basic Average Shares
348,770
347,332
344,413
342,393
Diluted Average Shares
348,770
377,521
344,413
342,393
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Comprehensive loss
-$63,774K
(-6.51%↓ Y/Y)
Net loss
-$62,840K
(-6.50%↓ Y/Y)
Currency translation
adjustment
$471K
(-27.09%↓ Y/Y)
Change in unrealized
loss on...
-$463K
(-105.78%↓ Y/Y)
Income (loss) before
income taxes
-$62,840K
(-6.50%↓ Y/Y)
Product
$23,192K
(1773.34%↑ Y/Y)
License
$8,495K
(136.30%↑ Y/Y)
Loss from operations
-$51,036K
(19.74%↑ Y/Y)
Total other (expense)
income, net
-$11,804K
(-357.62%↓ Y/Y)
Total revenue
$31,687K
(555.64%↑ Y/Y)
Interest income
$4,596K
(-3.85%↓ Y/Y)
Realized gain (loss) on
marketable securities
$9K
(1000.00%↑ Y/Y)
Other income
$5K
(135.71%↑ Y/Y)
Net loss (gain) on
disposal of fixed assets
$1K
(102.94%↑ Y/Y)
Total costs and
expenses
$82,723K
(25.63%↑ Y/Y)
Loss on debt
extinguishment
-$9,472K
Interest expense
$6,759K
(1505.46%↑ Y/Y)
Investment advisory fees
$184K
(1.10%↑ Y/Y)
Selling, general and
administrative
$42,591K
(10.67%↑ Y/Y)
Research and development
$30,661K
(12.06%↑ Y/Y)
Cost of
collaboration and license...
$8,560K
Cost of sales
$911K
Buy us a coffee
cropped-static1-svg
Nuvation Bio Inc. (NUVB)
cropped-static1-svg
Nuvation Bio Inc. (NUVB)